Targeting skeletal metastases in prostate cancer with a novel VEGF121 fusion toxin

被引：0
|
作者：
Poblenz, AT [1 ]
Mohamedali, K [1 ]
Rosenblum, MG [1 ]
Darnay, BG [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2004年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S67 / S67
页数：1
相关论文
共 50 条
  • [1] Targeting of Tumor Neovasculature with GrB/VEGF121, a Novel Cytotoxic Fusion Protein
    Mohamedali, Khalid A.
    Rosenblum, Michael G.
    [J]. BIOMEDICINES, 2017, 5 (03)
  • [2] In vitro and in vivo studies of a VEGF121/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors
    Veenendaal, LM
    Jin, HQ
    Ran, S
    Cheung, L
    Navone, N
    Marks, JW
    Waltenberger, J
    Thorpe, P
    Rosenblum, MG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (12) : 7866 - 7871
  • [3] Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel
    Hsu, Andrew R.
    Cai, Weibo
    Veeravagu, Anand
    Mohamedali, Khalid A.
    Chen, Kai
    Kim, Sehoon
    Vogel, Hannes
    Hou, Lewis C.
    Tse, Victor
    Rosenblum, Michael G.
    Chen, Xiaoyuan
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (03) : 445 - 454
  • [4] Pharmacodynamics, tissue distribution, toxicity studies and antitumor efficacy of the vascular targeting fusion toxin VEGF121/rGel
    Mohamedali, Khalid A.
    Niu, Gang
    Luster, Troy A.
    Thorpe, Philip E.
    Gao, Haokao
    Chen, Xiaoyuan
    Rosenblum, Michael G.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2012, 84 (11) : 1534 - 1540
  • [5] Targeting prostate cancer osteoblastic progression with VEGF121/rGeI, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature
    Mohamedali, Khalid A.
    Li, Zhi Gang
    Starbuck, Michael W.
    Wan, Xinhai
    Yang, Jun
    Kim, Sehoon
    Zhang, Weihe
    Navone, Nora M.
    Rosenblum, Michael G.
    [J]. CANCER RESEARCH, 2011, 71
  • [6] The vascular-targeting fusion toxin VEGF121/rGel inhibits the growth of orthotopic human bladder carcinoma tumors
    Mohamedali, KA
    Kedar, D
    Sweeney, P
    Kamat, A
    Davis, DW
    Eve, BY
    Huang, S
    Thorpe, PE
    Dinney, CP
    Rosenblum, MG
    [J]. NEOPLASIA, 2005, 7 (10): : 912 - 920
  • [7] Photochemical internalization augments tumor vascular cytotoxicity and specificity of VEGF121/rGel fusion toxin
    Weyergang, Anette
    Cheung, Lawrence H.
    Rosenblum, Michael G.
    Mohamedali, Khalid A.
    Peng, Qian
    Waltenberger, Johannes
    Berg, Kristian
    [J]. JOURNAL OF CONTROLLED RELEASE, 2014, 180 : 1 - 9
  • [8] Targeting prostate cancer skeletal metastases
    Keller, ET
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1567 - 1568
  • [9] Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121/rGel
    Mohamedali, Khalid A.
    Poblenz, Ann T.
    Sikes, Charles R.
    Navone, Nora M.
    Thorpe, Philip E.
    Darnay, Bryant G.
    Rosenblum, Michael G.
    [J]. CANCER RESEARCH, 2006, 66 (22) : 10919 - 10928
  • [10] Inhibition of Prostate Cancer Osteoblastic Progression with VEGF121/rGel, a Single Agent Targeting Osteoblasts, Osteoclasts, and Tumor Neovasculature
    Mohamedali, Khalid A.
    Li, Zhi Gang
    Starbuck, Michael W.
    Wan, Xinhai
    Yang, Jun
    Kim, Sehoon
    Zhang, Wendy
    Rosenblum, Michael G.
    Navone, Nora M.
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (08) : 2328 - 2338
12345